Massachusetts Patent of the Month

Crosswalk Therapeutics has unveiled a significant advancement in enzyme replacement therapy with its newly patented invention, “Human alpha-galactosidase variants” (U.S. Patent No. 12286655). [...]

SurgiBox Inc., a Cambridge-based medical device innovator, has been granted U.S. Patent No. 12,250,329 for its groundbreaking invention titled “Systems and methods for using blockchain to [...]

Atea Pharmaceuticals has developed an innovative oral antiviral treatment effective against SARS-CoV-2 (COVID-19) and other coronaviruses. At the heart of this advancement is Compound 1, a purine [...]